Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander J Thompson

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
Gastroenterology|April 28, 2012
Genetic factors and hepatitis C virus infectionAlexander J Thompson
Gastroenterology|April 2, 2017
Hepatocellular Carcinoma After Sustained Virologic Response: Leave No One BehindJessica Howell, Alexander J Thompson
Hepatology (Baltimore, Md.)|November 4, 2025
Commentary - AASLD Practice Guideline on treatment of chronic hepatitis B (2025 Update)Alexander J Thompson, Markus Cornberg
Antiviral Therapy|November 29, 2012
Direct-acting antiviral agents for the treatment of HCVAlexander J Thompson, Stephen Locarnini
Journal of Gastroenterology and Hepatology|September 16, 2011
Host genomics and HCV treatment responsePaul J Clark, Alexander J Thompson
Hepatic Medicine : Evidence and Research|November 21, 2015
Interferon-free combination therapies for the treatment of hepatitis C: current insightsJacinta A Holmes, Alexander J Thompson
Hepatology (Baltimore, Md.)|April 19, 2012
Will IL28B polymorphism remain relevant in the era of direct-acting antiviral agents for hepatitis C virus?Alexander J Thompson, John G McHutchison
Cold Spring Harbor Perspectives in Medicine|November 1, 2014
Viral hepatitis B: clinical and epidemiological characteristicsGregory S Burns, Alexander J Thompson
The Medical Journal of Australia|April 2, 2025
The potential benefits of a needle and syringe program in Australian prisonsAlexander J Thompson, Michael H Levy
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 13, 2019
Estimating Joint Health Condition Utility ValuesAlexander J Thompson, Matthew Sutton, Katherine Payne
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
Gastroenterology|April 28, 2012
Genetic factors and hepatitis C virus infectionAlexander J Thompson
Gastroenterology|April 2, 2017
Hepatocellular Carcinoma After Sustained Virologic Response: Leave No One BehindJessica Howell, Alexander J Thompson
Hepatology (Baltimore, Md.)|November 4, 2025
Commentary - AASLD Practice Guideline on treatment of chronic hepatitis B (2025 Update)Alexander J Thompson, Markus Cornberg
Antiviral Therapy|November 29, 2012
Direct-acting antiviral agents for the treatment of HCVAlexander J Thompson, Stephen Locarnini
Journal of Gastroenterology and Hepatology|September 16, 2011
Host genomics and HCV treatment responsePaul J Clark, Alexander J Thompson
Hepatic Medicine : Evidence and Research|November 21, 2015
Interferon-free combination therapies for the treatment of hepatitis C: current insightsJacinta A Holmes, Alexander J Thompson
Hepatology (Baltimore, Md.)|April 19, 2012
Will IL28B polymorphism remain relevant in the era of direct-acting antiviral agents for hepatitis C virus?Alexander J Thompson, John G McHutchison
Cold Spring Harbor Perspectives in Medicine|November 1, 2014
Viral hepatitis B: clinical and epidemiological characteristicsGregory S Burns, Alexander J Thompson
The Medical Journal of Australia|April 2, 2025
The potential benefits of a needle and syringe program in Australian prisonsAlexander J Thompson, Michael H Levy
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 13, 2019
Estimating Joint Health Condition Utility ValuesAlexander J Thompson, Matthew Sutton, Katherine Payne
Pageof 18